Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
MO BIO Laboratories Launches a New Kit for FFPE Tissue RNA Isolation
Monday, May 12, 2014
This latest kit features a very efficient protocol which includes complete lysis and extraction of total RNA from formalin-fixed, paraffin-embedded tissues without the use of toxic organic solvents.

OGT Launch Cancer Sequencing Panel at ACGS
Wednesday, April 30, 2014
Accurate solid tumour profiling for clinical and translational research

Illumina Launches VeriSeq PGS
Tuesday, April 29, 2014
Next-generation sequencing solution for preimplantation genetic screening offers increased scalability.

Silicon Mechanics Now Offers NVIDIA Tesla K40 GPU Accelerator
Saturday, April 26, 2014
Solve the most demanding HPC and big data challenges with 12GB of memory.

Next-Generation Gene Sequencing from Athena Streamlines Epilepsy Diagnosis
Thursday, April 24, 2014
Test services to be unveiled at the AAN Annual Meeting, April 26 - May 4 in Philadelphia.

Fluxion Biosciences Introduces IsoFlux™ NGS Assay Kits
Tuesday, April 22, 2014
New kits enable mutation detection from circulating tumor cells using next-generation sequencing.

Fight Against Illegal Poaching and Trafficking
Tuesday, April 22, 2014
FLUIDX joins the Smithsonian project in endangered species.

Life Technologies Releases New Research Tool
Tuesday, April 08, 2014
Oncomine NGS RNA-Seq Gene Expression Browser extends the Oncomine NGS Power Tools product offering.

QIAGEN Expands Product Portfolio for NGS and Cancer Research
Saturday, April 05, 2014
New innovative product launches at AACR Annual Meeting add to broad portfolio of NGS solutions.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 212
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv